晚期卵巢癌肿瘤细胞减灭术后肠道恢复(REACT)研究
本研究评估原发性或复发性卵巢癌肿瘤细胞减灭术后低位前切除综合征(LARS)的患病率,并识别肠道功能障碍的危险因素,评估泌尿与性症状及暂时性造口对生活质量的影响。430例评估肠道功能障碍的患者中8.8%报告LARS(5.3%轻度,3.5%重度),慢性便秘更常见(48.4%,包括13.5%重度病例)。低位肠切除(≤5 cm)是轻度和重度LARS及轻度和重度便秘的最强预测因素。
要点
- 430例评估肠道功能障碍的患者中8.8%报告LARS,慢性便秘更常见(48.4%)。
- 低位肠切除(≤5 cm)是轻度和重度LARS及便秘的最强预测因素。
- 泌尿功能障碍影响35.2%患者,性功能障碍高度流行(68%)。
核心结论
- 本研究强调卵巢癌肿瘤细胞减灭术后肠道功能障碍的显著负担,重度LARS不常见但慢性便秘是更突出的问题。
- 低位切除高度(≤5 cm)是最强预测因素,淋巴清扫和疾病复发也有额外关联。
- 泌尿和性功能障碍高发凸显多学科方法优化生存者照护的需求。
研究设计与样本
- 采用经验证问卷评估术后肠道(LARS评分、KESS)、泌尿(BFLUTS)、性(FSFI)功能障碍及造口患者生活质量(STOMA-QoL),用逻辑回归分析识别预测因素。
- 评估430例患者的肠道功能障碍。
主要发现
- 430例评估肠道功能障碍的患者中8.8%报告LARS(5.3%轻度,3.5%重度)。
- 慢性便秘更常见(48.4%,包括13.5%重度病例)。
- 低位肠切除(≤5 cm)是轻度和重度LARS(p < 0.001)及轻度和重度便秘(p = 0.009和p = 0.019)的最强预测因素。
- 重度便秘还与腰主动脉淋巴结清扫(OR 1.937,p = 0.031)和疾病复发(OR 2.095,p = 0.021)相关。
- 泌尿功能障碍影响35.2%患者,影响8.9%患者的生活质量;性功能障碍高度流行(68%)。造口患者生活质量随时间改善(p = 0.001)但仍欠佳。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study aims to assess the prevalence of low anterior resection syndrome (LARS) in patients undergoing cytoreductive surgery for primary or recurrent ovarian cancer. Additionally, it identifies risk factors for bowel dysfunction, assesses urinary and sexual symptoms, examines the impact of diverting ostomy on quality-of-life. METHODS: Validated questionnaires assessed postoperative bowel (LARS score, KESS), urinary (BFLUTS), and sexual (FSFI) dysfunction, as well as quality-of-life in ostomized patients (STOMA-QoL). Logistic regression analyses identified predictive factors. RESULTS: Among 430 patients assessed for bowel dysfunction 8.8 % reported LARS (5.3 % minor, 3.5 % major), while chronic constipation was more prevalent (48.4 %, including 13.5 % severe cases). Low bowel resection (≤5 cm) was the strongest predictor of both minor and major LARS (p < 0.001) and minor and major constipation (p = 0.009 and p = 0.019). Severe constipation was additionally associated with lumboaortic lymphadenectomy (OR 1.937, p = 0.031) and disease recurrence (OR 2.095, p = 0.021). Urinary dysfunction affected 35.2 % of patients, impacting quality-of-life in 8.9 %. Sexual dysfunction was highly prevalent (68 %). Among ostomized patients, quality-of-life improved over time (p = 0.001) but remained suboptimal. CONCLUSIONS: This study highlights the significant burden of postoperative bowel dysfunction in ovarian cancer patients undergoing cytoreductive surgery. While major LARS was uncommon, chronic constipation emerged as a more prominent issue. Low resection height (≤5 cm) was the strongest predictor of dysfunction, with additional associations identified for lymphadenectomy and disease recurrence. High rates of urinary and sexual dysfunction highlight the need for a multidisciplinary approach to optimize survivorship care.
引用
- Vargiu V, Rosati A, Santullo F, et al. REACT bowel REcovery after CyToreductive surgery for advanced ovarian cancer. Gynecol Oncol. 2025. PMID: 40517451. doi:10.1016/j.ygyno.2025.06.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。